Skip to content
ABOUT US
Our Science
PARTNERSHIPS
News
Publications
CAREERS
ABOUT US
Our Science
PARTNERSHIPS
News
Publications
CAREERS
CONTACT US
IN THE NEWS
THE LATEST NEWS
PRESS RELEASES
IN THE NEWS
EVENTS
PRESS RELEASES
IN THE NEWS
EVENTS
Oct 14, 2022
Intelligent Technology Brings Companies To A New Moment Of Truth
Aug 23, 2017
BioCentury highlights GNS-Alexion partnership
Aug 21, 2017
FierceBiotech features Alexion-GNS Partnership Targeting Rare Diseases
Aug 20, 2017
Rare Disease Report Covers Alexion-GNS REFS Licensing Agreement
Aug 18, 2017
GNS Co-Founder Iya Khalil Interviewed in The Pink Sheet
Aug 10, 2017
GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases
Jun 19, 2017
GNS Healthcare Announces Collaboration to Power Cancer Drug Development with REFS™ Causal Machine Learning and Simulation AI Platform
May 31, 2017
GNS Healthcare Uncovers Novel Targets for Triple-Negative Breast Cancer Using Causal Machine Learning and Simulation Platform REFS™
Dec 07, 2016
GenomeWeb Article Offers Insight on GNS-Celgene Deal and Growing Demand for Causal Modeling
Dec 06, 2016
Outsourcing Pharma Puts Spotlight on Power of Causality, Highlights GNS-Celgene Deal Licensing REFS
Load More
ABOUT US
Our Science
PARTNERSHIPS
News
Publications
CAREERS
ABOUT US
Our Science
PARTNERSHIPS
News
Publications
CAREERS
CONTACT US